PP_1170x120_10-25-21

fizer/BioNTech COVID-19 vaccine for children

FDA advisers back Pfizer/BioNTech COVID-19 vaccine for children

FDA advisers back Pfizer/BioNTech COVID-19 vaccine for children

WASHINGTON – An expert panel on Tuesday voted overwhelmingly to recommend the U.S. Food and Drug Administration authorize the Pfizer and BioNTech SE COVID-19 vaccine for children ages 5 to 11, saying the benefits of inoculation outweigh the risks. An authorization for that age group would be would be an important regulatory step toward reaching